Evidence map›Paper›PMID 16527887›Full record

ArticleBlood2006

Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

Ola Landgren, Eric A Engels, Neil E Caporaso, Gloria Gridley, Lene Mellemkjaer, Kari Hemminki, Martha S Linet, Lynn R Goldin

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2010
    Article
  15. Autoimmune complications in chronic lymphocytic leukaemia (CLL).Best practice & research. Clinical haematology · 2010
    Review
  16. Review
  17. Autoimmunity and lymphomagenesis.International journal of cancer · 2009
    Review
  18. B-cell clones as early markers for chronic lymphocytic leukemia.The New England journal of medicine · 2009
    Article
  19. Article
  20. Shared susceptibility for celiac disease and inflammatory bowel disease?Scandinavian journal of gastroenterology · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Ola LandgrenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892-7236, USA. landgreo@mail.nih.gov
Eric A Engels
Neil E Caporaso
Gloria Gridley
Lene Mellemkjaer
Kari Hemminki
Martha S Linet
Lynn R Goldin
National Cancer Institute · USDanish Cancer Society · DKKarolinska Institutet · SE

Funding

Genetic EpidemiologyZIACP005803 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GOLDSTEIN, ALISA · 2009 to 2025
$24.8M
STUDIES OF PERSONS AT HIGH RISK OF CANCER--GENETIC EPIDEMIOLOGYZ01CP005803 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GOLDSTEIN, ALISA · 1995 to 2008
$1.5M
Intramural NIH HHS
6 · The paper itself

Abstract

A population-based case-control study was conducted to evaluate risk of developing chronic lymphocytic leukemia (CLL) associated with personal and/or family history of autoimmune and related diseases. Data were obtained for all (n = 7764) patients diagnosed with CLL in Sweden and Denmark over a 40-year period and with linkable relatives, 16,658 matched control subjects, and first-degree relatives of patients (n = 17,991) and control subjects (n = 39,388). Odds ratios (ORs) were calculated to quantify risk of CLL in relation to personal/family history of 32 autoimmune and related disorders. The risk of CLL was significantly increased among subjects with a personal history of pernicious anemia (OR = 1.94; 1.18-3.18), mainly in the 0- to 1-year latency period. A significantly decreased risk of CLL was found among individuals with a personal history of chronic rheumatic heart disease (OR = 0.55; 0.33-0.93), particularly persons with a long latency (10+ years) between the 2 conditions. We found no association between personal or familial occurrence of other autoimmune or related disorders and CLL. If our results are confirmed, mechanistic studies examining how pernicious anemia might promote increased occurrence of CLL and how chronic rheumatic heart disease protects against CLL, perhaps related to long-term antibiotics use, may provide insights to the as-yet-unknown etiology of CLL.

Indexed as

AgedAnemia, PerniciousAutoimmune DiseasesCase-Control StudiesDenmarkFamily HealthFemaleHumansLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedOdds RatioRegistriesRheumatic Heart DiseaseRisk FactorsSweden

Identifiers

PMID16527887
PMCPMC1895837
OpenAlexW2006656840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.